Roivant Sciences Ltd (ROIV)

Operating profit margin

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Operating income (ttm) US$ in thousands -1,021,245 -1,002,280 4,332,981 4,951,148 4,794,921 4,826,755 -514,453 -1,071,673 -1,077,569 -1,108,689 -1,074,384 -1,478,047 -1,350,125 -1,625,673 -1,638,720 -1,110,832 -1,070,898 -530,064
Revenue (ttm) US$ in thousands 76,195 97,555 125,677 158,303 124,795 123,241 103,153 78,585 61,280 43,127 50,416 51,870 55,286 61,209 42,618 29,954 23,795 8,649
Operating profit margin -1,340.30% -1,027.40% 3,447.71% 3,127.64% 3,842.24% 3,916.52% -498.73% -1,363.71% -1,758.44% -2,570.75% -2,131.04% -2,849.52% -2,442.07% -2,655.94% -3,845.14% -3,708.46% -4,500.52% -6,128.62%

March 31, 2025 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-1,021,245K ÷ $76,195K
= -1,340.30%

Roivant Sciences Ltd's operating profit margin has shown a significant improvement over the quarters, transitioning from negative values to positive values. The company experienced a steady decline in negative operating profit margins from December 31, 2020 (-6,128.62%) to September 30, 2023 (-498.73%). This trend reversed sharply in the subsequent quarters, with the company achieving positive operating profit margins, reaching 3,916.52% by December 31, 2023. However, there was a slight decrease in the operating profit margin to -1,340.30% as of March 31, 2025. The positive progression in the operating profit margin demonstrates the company's efforts to enhance profitability and efficiency in its operations.